ISSN: 0903-1936

Journal Home

Journal Guideline

European Respiratory Journal Q1 Unclaimed

European Respiratory Society Switzerland

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

European Respiratory Journal is a journal indexed in SJR in Medicine (miscellaneous) and Pulmonary and Respiratory Medicine with an H index of 282. It has a price of 3250 €. It has an SJR impact factor of 3,81 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,81.

European Respiratory Journal focuses its scope in these topics and keywords: asthma, lung, pulmonary, function, disease, adults, inhaled, european, risk, arterial, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Pulmonary and Respiratory Medicine (Q1)

Price

3250 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,81

SJR Impact factor

282

H Index

371

Total Docs (Last Year)

1759

Total Docs (3 years)

12796

Total Refs

12994

Total Cites (3 years)

981

Citable Docs (3 years)

7.12

Cites/Doc (2 years)

34.49

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?

Rapid detection of multidrug-resistant tuberculosis

Polypoid bronchial lesions due to Scedosporium apiospermum in a patient with Mycobacterium avium complex pulmonary disease

Breastfeeding is associated with increased lung function at 18 years of age: a cohort study

Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection

Detection of immunoglobulins G and A to Aspergillus fumigatus by immunoblot analysis for monitoring Aspergillus-induced lung diseases

Lung transplantation: beyond palliation

Health consequences associated with frequent wheezing in adolescents without asthma diagnosis

Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease

Arterial oxygenation does not predict the outcome of patients with acute respiratory failure

Effects of mechanical ventilation on diaphragm function and biology

The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis

SHOW MORE ARTICLES

An out-patient nutritional supplementation programme in COPD patients

Interval training as an alternative modality to continuous exercise in patients with COPD

Bronchiolitis obliterans organizing pneumonia associated with polymyalgia rheumatica

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

Clinical determinants of exacerbations in severe, early-onset COPD

Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study

Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages

Pneumococcal vaccination: current and future issues

Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern

Bronchoalveolar Lavage Fluid Lymphocytosis in Chronic Hypersensitivity Pneumonitis: A Systematic Review and Meta-Analysis

Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibioticsin vitro